What is the Purpose of this Study?
Primary Objective: Assess overall sensitivity and specificity of Oncoguard Liver for hepatocellular cancer (HCC) detection in a surveillance population. Secondary Objective(s): Assess performance of Oncoguard Liver in confirmed HCC and non-HCC population. Assess early-stage sensitivity of Oncoguard Liver for HCC detection in a surveillance population.
Eligibility
- * All Subjects:
- 1. Subject is 18 years of age or older
- 2. Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of data, including personal health data, to the study investigator and sponsor
Where can I participate?
CS Cancer at Cedars-Sinai Medical Center
More about this Clinical Trial
What is the full name of this clinical trial?
ALTUS2021-01: ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma Test in Subjects with Increased Risk